Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LNPEP | Q9UIQ6 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.35 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 7/20 | 0.34 |
| ▸ | TMPRSS15 | P98073 | 7/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SCN1A | P35498 | 1/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11921759 | 0.91 | TSHR (0.42) | LNPEPTSHRERAP2ERAP1LMNA | |
| SCHEMBL15259409 | 0.79 | TRPA1 (0.35) | TSHRLMNACYP3A4PRSS1TMPRSS15 | |
| SCHEMBL11925982 | 0.77 | TSHR (0.41) | TSHRPRSS1TMPRSS15CTSL | |
| SCHEMBL11921786 | 0.76 | GAA (0.40) | LNPEPTSHRLMNACYP1A2CYP3A4 | |
| SCHEMBL16270510 | 0.75 | LMNA (0.49) | TSHRLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL11921787 | 0.74 | LMNA (0.36) | LNPEPTSHRLMNACYP1A2CYP3A4 | |
| SCHEMBL16270243 | 0.73 | LMNA (0.47) | TSHRLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL16270205 | 0.73 | LMNA (0.47) | TSHRLMNACYP1A2CYP3A4MAOA | |
| SCHEMBL11921777 | 0.72 | CTSL (0.39) | TSHRPRSS1CTSL | |
| SCHEMBL11921789 | 0.72 | NPC1 (0.41) | TSHRLMNACYP1A2CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2018-07-12 | — | — | US | disclosed |
| US-9868696-B2 | Amino acid derivatives and absorbable polymers therefrom | Bezwada Biomedial, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | disclosed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | disclosed |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-06-25 | — | — | US | disclosed |
| US-9012677-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-9012677-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-8901341-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8901341-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8461372-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC | 2013-06-11 | — | — | US | disclosed |
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | SLC7A1, SLC3A2, BCAT2 | LNPEP 589/4885TSHR 2422/4885ERAP2 828/4885 |
| US-20150065586-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | LNPEP 568/4885TSHR 2352/4885ERAP2 903/4885 |
| US-20130245133-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | LNPEP 568/4885TSHR 2352/4885ERAP2 903/4885 |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | LNPEP 568/4885TSHR 2352/4885ERAP2 903/4885 |
| US-20150174290-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | LNPEP 568/4885TSHR 2352/4885ERAP2 903/4885 |
| US-20180194717-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | LNPEP 568/4885TSHR 2352/4885ERAP2 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.